Organigram Sees BAT Plan To Increase Stake To 45% With $124 Million Investment
While Canopy Growth (TSX: WEED) may have lost the interest of its major investor Constellation Brands (NYSE: STZ), Organigram Holdings
Read moreWhile Canopy Growth (TSX: WEED) may have lost the interest of its major investor Constellation Brands (NYSE: STZ), Organigram Holdings
Read moreOrganigram Holdings (TSX: OGI) appears to have finally begun to hit it stride, several years into the legal cannabis market.
Read moreIt appears that British American Tobacco, or BAT, is still focused on maintaining its stake in Organigram Holdings (TSX: OGI).
Read moreOn January 11th, Organigram Holdings (TSX: OGI) issued its second fiscal quarter earnings for 2022. The company reported net revenues
Read moreOn January 11th, Organigram Holdings (TSX: OGI) issued its second fiscal quarter of 2022. The company reported net revenues of
Read moreOrganigram Holdings (TSX: OGI) has finally done it. The company has finally posted a positive gross margin quarter, although just
Read moreOrganigram Holdings (TSX: OGI) evidently intends to fix its profitability issues by acquiring additional cultivation capacity in Canada. The firm
Read moreOn November 23rd, Organigram Holdings (TSX: OGI) announced its fourth quarter fiscal 2021 results. The company reported net revenues of
Read moreOn November 23rd, Organigram Holdings (TSX: OGI) announced its fourth quarter fiscal 2021 results. The company reported net revenues of
Read moreOrganigram Holdings (TSX: OGI) this morning reported its fiscal fourth quarter financial results, posting net revenues of $24.9 million. The
Read more